Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × lutetium Lu 177 dotatate × Dermatologic × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 16 NET 15 CNS 8 Gastrointestinal 5 Genitourinary 2 Sarcoma 1 Other neoplasm 1 Dermatologic 1

Conditions

Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 66 Nivolumab 61 Ipilimumab 34 Cyclophosphamide 22 Specimen Handling 17 Magnetic Resonance Spectroscopy 16 Biopsy 15 cemiplimab 14 relatlimab 13 fludarabine 13 Opdualag 13 Blood Specimen Collection 11 binimetinib 10 aldesleukin 9 Radiosurgery 9 Interleukin-2 9 encorafenib 8 atezolizumab 7 Surgical Procedures, Operative 7 Paclitaxel 7 Immunotherapy 7 tebentafusp 6 mogamulizumab 6 fludarabine phosphate 6 Temozolomide 6 Radiotherapy 6 Immunoglobulin G 6 CTLA-4 Antigen 6 Aminolevulinic Acid 6 Standard of Care 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05583708 2026-04-22

iPRRT

Weill Medical College of Cornell University

Phase 2 Recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡